DXCM DEXCOM INC revenue, earnings and financials

For the quarter ended June 30, 2026, DEXCOM INC reported revenue of $1.31B (up 13.1% from a year earlier), net income of $249M and diluted EPS of $0.64; over the last four quarters revenue was $4.97B and net income $1000M; for the fiscal year ended December 2025 revenue was $4.66B, up 15.6% on the year before.

DXCM annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $4.66B, gross profit $2.80B, operating income $912M, net income $836M (margin 17.9%), EPS $2.09
• Fiscal year ended Dec 2024: revenue $4.03B, gross profit $2.44B, operating income $600M, net income $576M (margin 14.3%), EPS $1.42
• Fiscal year ended Dec 2023: revenue $3.62B, gross profit $2.29B, operating income $598M, net income $542M (margin 14.9%), EPS $1.30
• Fiscal year ended Dec 2022: revenue $2.91B, gross profit $1.88B, operating income $391M, net income $341M (margin 11.7%), EPS $0.82
• Fiscal year ended Dec 2021: revenue $2.45B, gross profit $1.68B, operating income $266M, net income $217M (margin 8.9%), EPS $0.53

DXCM quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $1.31B (up 13.1% year over year), net income $249M, EPS $0.64
• Quarter ended Mar 31, 2026: revenue $1.19B (up 15.0% year over year), net income $200M, EPS $0.51
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.26B (up 13.1% year over year), net income $267M, EPS $0.67
• Quarter ended Sep 30, 2025: revenue $1.21B (up 21.6% year over year), net income $284M, EPS $0.70
• Quarter ended Jun 30, 2025: revenue $1.16B (up 15.2% year over year), net income $180M, EPS $0.45
• Quarter ended Mar 31, 2025: revenue $1.04B (up 12.5% year over year), net income $105M, EPS $0.27
• Quarter ended Dec 31, 2024 (from the annual report): revenue $1.11B (up 7.6% year over year), net income $152M, EPS $0.37
• Quarter ended Sep 30, 2024: revenue $994M (up 2.0% year over year), net income $135M, EPS $0.34
• Quarter ended Jun 30, 2024: revenue $1.00B (up 15.3% year over year), net income $144M, EPS $0.35
• Quarter ended Mar 31, 2024: revenue $921M (up 24.2% year over year), net income $146M, EPS $0.36
• Quarter ended Dec 31, 2023 (from the annual report): revenue $1.03B (up 26.9% year over year), net income $256M, EPS $0.61
• Quarter ended Sep 30, 2023: revenue $975M (up 26.7% year over year), net income $121M, EPS $0.29
• Quarter ended Jun 30, 2023: revenue $871M (up 25.2% year over year), net income $116M, EPS $0.28
• Quarter ended Mar 31, 2023: revenue $742M (up 17.9% year over year), net income $48.6M, EPS $0.12
• Quarter ended Dec 31, 2022 (from the annual report): revenue $815M (up 16.8% year over year), net income $91.8M, EPS $0.23
• Quarter ended Sep 30, 2022: revenue $770M (up 18.4% year over year), net income $101M, EPS $0.24
• Quarter ended Jun 30, 2022: revenue $696M (up 17.0% year over year), net income $50.9M, EPS $0.12
• Quarter ended Mar 31, 2022: revenue $629M (up 24.5% year over year), net income $97.3M, EPS $0.23
• Quarter ended Dec 31, 2021 (from the annual report): revenue $698M, net income −$5.30M, EPS −$0.43
• Quarter ended Sep 30, 2021: revenue $650M, net income $87.3M, EPS $0.21

DXCM cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $1.44B, share buybacks $500M
• Fiscal year ended Dec 2024: operating cash flow $990M, share buybacks $750M
• Fiscal year ended Dec 2023: operating cash flow $749M, share buybacks $689M
• Fiscal year ended Dec 2022: operating cash flow $670M, share buybacks $558M
• Fiscal year ended Dec 2021: operating cash flow $443M, share buybacks $0

DXCM balance sheet

• Jun 30, 2026: cash $1.11B, total assets $6.46B, total liabilities $3.83B, shareholders' equity $2.62B
• Mar 31, 2026: cash $1.12B, total assets $6.63B, total liabilities $3.68B, shareholders' equity $2.96B
• Dec 31, 2025: cash $918M, total assets $6.34B, total liabilities $3.59B, shareholders' equity $2.75B
• Sep 30, 2025: cash $1.84B, total assets $7.50B, total liabilities $4.77B, shareholders' equity $2.73B
• Jun 30, 2025: cash $1.16B, total assets $7.33B, total liabilities $4.75B, shareholders' equity $2.57B
• Mar 31, 2025: cash $905M, total assets $6.75B, total liabilities $4.49B, shareholders' equity $2.27B
• Dec 31, 2024: cash $606M, total assets $6.48B, total liabilities $4.38B, shareholders' equity $2.10B
• Sep 30, 2024: cash $621M, total assets $6.35B, total liabilities $4.37B, shareholders' equity $1.98B

What is DXCM's revenue?

DEXCOM INC reported $4.97B of revenue over its last four quarters, through June 30, 2026.

Is DXCM profitable?

Yes. DEXCOM INC earned $1000M over the last four quarters.

What is DXCM's EPS?

Diluted earnings per share over the last four quarters were $2.52; $0.64 in the latest quarter.

DXCM ownership and insider trades · All stocks